Q4 2024 Earnings Call Transcript February 11, 2025 Royalty Pharma plc misses on earnings expectations. Reported EPS is ...

A series of music benefit shows will be held in Richmond to support a cherished local musician recently diagnosed with cancer ...

Online oddsmakers seem to agree on which quarterback will win OSU's quarterback competition. They also have OSU facing an ...

Gilead Sciences posted fourth-quarter results that exceeded Wall Street expectations and forecast 2025 earnings above analyst estimates on Tuesday, and its shares rose nearly 5%. The quarterly results ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.3cY8rBmp.js ...

Christopher Hite; Vice Chairman, Executive Vice President; Royalty Pharma PLC Marshall Urist; Executive Vice President - Research and Investments; Royalty Pharma PLC Terrance Coyne; Chief Financial ...

Pablo Legorreta, CEO, highlighted strong 2024 performance, with Portfolio Receipts reaching $2.8 billion, at the high end of guidance and representing 13% growth in Royalty Receipts. He noted this ...

Gilead Sciences, Inc. ( NASDAQ: GILD) Q4 2024 Earnings Conference Call February 11, 2025 4:30 PM ET Jacquie Ross - SVP, Treasury & IR Daniel O'Day - Chairman, CEO Johanna Mercier - Chief Commercial ...

One of the guests told The Independent that Fox News did not ask him about his past political campaigns during his recent conversations with the network, adding that he’d appeared on the channel in ...